Company Registration No. 13708436 (England and Wales)
GYNAESPACE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
GYNAESPACE LIMITED
CONTENTS
Page
Company information
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
GYNAESPACE LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
64,438
80,605
Current assets
Debtors
4
194,300
26,295
Investments
5
20,500
16,000
Cash at bank and in hand
557,391
333,873
772,191
376,168
Creditors: amounts falling due within one year
6
(163,965)
(64,564)
Net current assets
608,226
311,604
Total assets less current liabilities
672,664
392,209
Creditors: amounts falling due after more than one year
7
(57,380)
(64,539)
Net assets
615,284
327,670
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
615,184
327,570
Total equity
615,284
327,670

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

GYNAESPACE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2025
31 October 2025
- 2 -
The financial statements were approved and signed by the director and authorised for issue on 30 July 2026
Dr. D Touqmatchi
Director
Company registration number 13708436 (England and Wales)
GYNAESPACE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2025
- 3 -
1
Accounting policies
Company information

Gynaespace Limited is a private company limited by shares incorporated in England and Wales. The registered office is Lynton House, 7-12 Tavistock Square, London, WC1H 9BQ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
33.33% straight line
Motor vehicles
25% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

GYNAESPACE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 4 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

GYNAESPACE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
1
Accounting policies
(Continued)
- 5 -
1.8
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
3
Tangible fixed assets
Computers
Motor vehicles
Total
£
£
£
Cost
At 1 November 2024
4,937
105,281
110,218
Additions
7,829
-
0
7,829
At 31 October 2025
12,766
105,281
118,047
Depreciation and impairment
At 1 November 2024
3,292
26,321
29,613
Depreciation charged in the year
4,256
19,740
23,996
At 31 October 2025
7,548
46,061
53,609
Carrying amount
At 31 October 2025
5,218
59,220
64,438
At 31 October 2024
1,645
78,960
80,605
GYNAESPACE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 OCTOBER 2025
- 6 -
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
184,818
26,295
Amounts owed by group undertakings
9,482
-
0
194,300
26,295
5
Current asset investments
2025
2024
£
£
Other investments
20,500
16,000
6
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
147,338
51,428
Other creditors
16,627
13,136
163,965
64,564
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
57,380
64,539
2025-10-312024-11-01falsefalsefalse30 July 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityDr. Dana Touqmatchi137084362024-11-012025-10-31137084362025-10-31137084362024-10-3113708436core:ComputerEquipment2025-10-3113708436core:MotorVehicles2025-10-3113708436core:ComputerEquipment2024-10-3113708436core:MotorVehicles2024-10-3113708436core:CurrentFinancialInstrumentscore:WithinOneYear2025-10-3113708436core:CurrentFinancialInstrumentscore:WithinOneYear2024-10-3113708436core:Non-currentFinancialInstrumentscore:AfterOneYear2025-10-3113708436core:Non-currentFinancialInstrumentscore:AfterOneYear2024-10-3113708436core:CurrentFinancialInstruments2025-10-3113708436core:CurrentFinancialInstruments2024-10-3113708436core:ShareCapital2025-10-3113708436core:ShareCapital2024-10-3113708436core:RetainedEarningsAccumulatedLosses2025-10-3113708436core:RetainedEarningsAccumulatedLosses2024-10-3113708436bus:Director12024-11-012025-10-3113708436core:ComputerEquipment2024-11-012025-10-3113708436core:MotorVehicles2024-11-012025-10-31137084362023-11-012024-10-3113708436core:ComputerEquipment2024-10-3113708436core:MotorVehicles2024-10-31137084362024-10-3113708436core:Non-currentFinancialInstruments2025-10-3113708436core:Non-currentFinancialInstruments2024-10-3113708436bus:PrivateLimitedCompanyLtd2024-11-012025-10-3113708436bus:SmallCompaniesRegimeForAccounts2024-11-012025-10-3113708436bus:FRS1022024-11-012025-10-3113708436bus:AuditExemptWithAccountantsReport2024-11-012025-10-3113708436bus:FullAccounts2024-11-012025-10-31xbrli:purexbrli:sharesiso4217:GBP